Aligos Therapeutics, Inc. · NASDAQ:ALGS

Woodline Partners LP reported a 5.20% stake in Aligos Therapeutics, Inc. (Schedule 13G)

Event Mar 31, 2025 · Filed May 15, 2025

Woodline Partners LP reported a 5.20% stake in Aligos Therapeutics, Inc., 315,383 shares, as a passive investor on Mar 31, 2025. Filed May 15, 2025 (Schedule 13G).

Stake
5.20%
Shares
315,383
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
Woodline Partners LP5.20%315,383

Source

View original at SEC

Related